Interventional Orthopedic Solutions Rochester Enters Into a Partnership with Regenexx®

Interventional Orthopedic Solutions Rochester is establishing its commitment to excellence in the field of Regenerative Orthopedics by entering into a partnership with Regenexx®, a worldwide network of specially trained physicians providing advanced, research-driven, regenerative orthopedic treatments.

The alliance brings cutting-edge, non-surgical orthopedic treatments to Minnesota residents suffering from sports injuries, spine pain, or degenerative diseases such as osteoarthritis.

“Being selected to represent the Regenexx brand in Minnesota speaks to the quality, skill, and care that we provide our patients,” said Catherine McBride, co-founder of the Rochester-based clinic. “Interventional Orthopedic Solutions is focused on providing the highest level of non-surgical orthopedic care in Minnesota and our partnership with Regenexx helps us achieve that goal.”

Interventional Orthopedic Solutions Rochester was founded by Dr. Russell Bergum, a long-time Minnesotan and a specialist in regenerative medicine and interventional orthopedics, and is focused on the treatment of musculoskeletal injuries and degenerative orthopedic conditions.

“All of our procedures are based on published, peer-reviewed research and incorporate the extensive Regenexx outcomes database tracking patient results from 2005 to the present, to guide treatment plans,” said Dr. Bergum, founder of IOS-Rochester. “Our goal is to get you back into doing the things you love to do. This is now possible through the state-of-the-art non-surgical orthobiologic treatments that we offer.”

Interventional Orthobiologics is a specialty that focuses on using your body’s natural healing agents to treat orthopedic injuries with the goal of reducing pain and improving joint function. The variety of orthobiologics available to Regenexx physicians, such as bone marrow aspirate concentrate (which contains stem cells) and platelet-rich plasma (PRP), allow them to create a treatment plan to best support your recovery. Regenexx procedures can be used in the treatment of conditions such as arthritis, back pain, and injury to ligaments, tendons, cartilage, spinal discs, or bones.

Regenexx physicians are required to have extensive experience and training in performing precise injection-based procedures using image guidance for a range of body parts and injuries. With strict acceptance criteria, Regenexx only chooses the most qualified physicians to join their network. Interventional Orthopedic Solutions Dr. Russell Bergum is ranked among them.

 

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.